Cognition Therapeutics Inc
CGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001455365
No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Cognition Therapeutics Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +6 vs. Q3 2024
- Shares held
- 11.1M
- +6.84M (+161.3%) vs. Q3 2024
- Total value
- $7.78M
- +$5.79M (+291.4%) vs. Q3 2024
- New holders
- 8
- 12 more added
- Sold out
- 2
- 9 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $26.0M |
| Q1 2026 | 75 | $16.3M |
| Q4 2025 | 78 | $28.9M |
| Q3 2025 | 68 | $28.7M |
| Q2 2025 | 48 | $3.50M |
| Q1 2025 | 51 | $4.89M |
| Q4 2024 | 45 | $7.78M |
| Q3 2024 | 40 | $1.99M |
| Q2 2024 | 46 | $8.82M |
| Q1 2024 | 47 | $12.9M |
| Q4 2023 | 37 | $13.2M |
| Q3 2023 | 36 | $10.4M |
| Q2 2023 | 35 | $13.0M |
| Q1 2023 | 32 | $14.1M |
| Q4 2022 | 34 | $10.1M |
| Q3 2022 | 31 | $9.67M |
| Q2 2022 | 28 | $11.4M |
| Q1 2022 | 27 | $4.58M |
| Q4 2021 | 20 | $8.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Cognition Therapeutics Inc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 6,000,000 | $4.21M | 4.47% | +6,000,000 | New |
| Vanguard Group Inc | 1,239,567 | $868.9K | 0.00% | −2,987−0.2% | Reduced |
| Sigma Planning Corp | 614,490 | $430.9K | 0.01% | +417,300+211.6% | Added |
| Alyeska Investment Group, L.P. | 500,000 | $350.6K | 0.00% | 00.0% | Unchanged |
| Voss Capital, LLC | 500,000 | $350.6K | 0.03% | +500,000 | New |
| Geode Capital Management, LLC | 352,348 | $247.1K | 0.00% | +28,705+8.9% | Added |
| American Financial Group Inc | 205,000 | $143.8K | 0.07% | 00.0% | Unchanged |
| CM Management, LLC | 200,000 | $140.3K | 0.13% | −50,000−20.0% | Reduced |
| Kestra Advisory Services, LLC | 177,434 | $124.4K | 0.00% | −11,000−5.8% | Reduced |
| BlackRock, Inc. | 156,039 | $109.4K | 0.00% | +494+0.3% | Added |
| State Street Corp | 121,850 | $85.5K | 0.00% | +59,100+94.2% | Added |
| Acadian Asset Management LLC | 110,233 | $76.0K | 0.00% | −30,710−21.8% | Reduced |
| Commonwealth Equity Services, LLC | 90,665 | $64.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 91,100 | $63.9K | 0.00% | +2,400+2.7% | Added |
| Virtu Financial LLC | 80,180 | $56.0K | 0.00% | +22,949+40.1% | Added |
| Two Sigma Investments, LP | 53,691 | $37.7K | 0.00% | +42,321+372.2% | Added |
| Fca Corp | 51,471 | $36.1K | 0.01% | 00.0% | Unchanged |
| Circle Wealth Management, LLC | 48,842 | $34.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 47,485 | $33.3K | 0.00% | 00.0% | Unchanged |
| Castle Wealth Management LLC | 43,380 | $30.4K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 41,112 | $28.8K | 0.00% | −156,747−79.2% | Reduced |
| SG Americas Securities, LLC | 37,108 | $26.0K | 0.00% | +37,108 | New |
| Bangor Savings Bank | 34,019 | $23.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 31,874 | $22.4K | 0.00% | −44,826−58.4% | Reduced |
| Tocqueville Asset Management L.P. | 28,500 | $20.0K | 0.00% | +5,000+21.3% | Added |
| Northeast Financial Consultants Inc | 24,500 | $17.2K | 0.00% | 00.0% | Unchanged |
| WSFS Capital Management, LLC | 23,337 | $16.4K | 0.00% | +23,337 | New |
| Tower Research Capital LLC (TRC) | 20,970 | $14.7K | 0.00% | +9,980+90.8% | Added |
| HighTower Advisors, LLC | 19,462 | $13.6K | 0.00% | −3,500−15.2% | Reduced |
| Advisor Group Holdings, Inc. | 19,000 | $13.3K | 0.00% | +17,200+955.6% | Added |
| Raymond James Financial Inc | 17,500 | $12.3K | 0.00% | +17,500 | New |
| Morgan Stanley | 16,873 | $11.8K | 0.00% | +15,873+1,587.3% | Added |
| Mercer Global Advisors Inc | 16,051 | $11.3K | 0.00% | 00.0% | Unchanged |
| Bessemer Group Inc | 13,797 | $10.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 13,741 | $9.64K | 0.00% | +13,741 | New |
| Smith Anglin Financial, LLC | 12,000 | $8.42K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,040 | $7.04K | 0.00% | −12,690−55.8% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 10,000 | $7.01K | 0.00% | +10,000 | New |
| Northwestern Mutual Wealth Management Co | 5,867 | $4.12K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5,290 | $3.71K | 0.00% | +11+0.2% | Added |
| Bray Capital Advisors | 2,250 | $1.58K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,000 | $701 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 200 | $141 | 0.00% | +200 | New |
| JPMorgan Chase & Co | 75 | $53 | 0.00% | −3−3.8% | Reduced |
| FMR LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Texas Capital Bank Wealth Management Services Inc | 0 | $0 | 0.00% | −55,395−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |